Ex-ImClone CEO Waksal returns to biotech with deal

NEW YORK, Oct 25 (Reuters) - Sam Waksal, the former chief executive of ImClone Systems Inc , whose insider trading scam sent him and Martha Stewart to prison, on Monday announced an acquisition meant to catapult him back into the biotech game.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.